1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6F5173514F077BFBE65257B9E003EDDC1
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/insights/F5173514F077BFBE65257B9E003EDDC1?OpenDocument
18
19OpenDocument
2052.23.231.207
21
22
23globalbenchmarking.com
24/bestp/domrep.nsf
25Main






> Our Expertise > Clinical Operations

Clinical Operations

To keep up with changing industry trends and regulations, bio-pharma and medical device companies are changing their approach to clinical trials, with focus shifting from efficiency to effectiveness. While it is still critical to ensure tightly designed clinical trials to reduce time to market and address multiple indications, increased outsourcing means it is now also critical to ensure tightly monitored clinical trials for quality control.


Specifically, executives use our benchmarking services to:

  • Site and patient selection
  • Designing and executing trials, pre-clinical through Phase IV
  • Selecting clinical investigators
  • Working with regulators
  • Clinical trial adherence
  • Communicating clinical trial results
  • Maintaining clinical data security
  • Managing clinical trials given regional difference


To assist clinical affairs & regulatory leaders, Best Practices, LLC provides best practices and performance metrics for effective clinical programs. Benchmarked areas include:


  • Christopher Bogan

    Christopher Bogan

    President and CEO

    Chris has 26 years of experience in helping U.S. companies bring new biopharmaceutical products to market. Over that time, he has helped dozens of new brands launch assets totaling hundreds of billions of dollars.

    Phone: (919)-767-9228

    Schedule a Meeting

To assist clinical affairs & regulatory leaders, Best Practices, LLC provides best practices and performance metrics for effective clinical programs. Benchmarked areas include:

Clinical Operations


  • Recruiting high-performing investigators
  • Clinical investigator relationship management systems
  • Communicating the value of clinical trials to potential investigators
  • Bioequivalence process performance measurement